Skip to main navigation Skip to search Skip to main content

Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: Results of an open-label, randomized, phase 3b controlled study in healthy infants

  • Arturo Abdelnour
  • , Peter E. Silas
  • , Marta Raquel Valdés Lamas
  • , Carlos Fernándo Grazioso Aragón
  • , Nan Chang Chiu
  • , Cheng Hsun Chiu
  • , Teobaldo Herrera Acuña
  • , Tirza De León Castrejón
  • , Allen Izu
  • , Tatjana Odrljin
  • , Igor Smolenov
  • , Matthew Hohenboken
  • , Peter M. Dull*
  • *Corresponding author for this work
  • Apdo 607-1150 La Uruca
  • Wee Care Pediatrics
  • Guanchipelin
  • Centro de Investigaciones en Pediatría
  • Mackay Memorial Hospital Taiwan
  • Instituto de Investigación Nutricional
  • Hospital Materno Infantil José Domingo de Obaldía
  • Novartis Vaccines and Diagnostics, Inc.

Research output: Contribution to journalJournal Article peer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: Results of an open-label, randomized, phase 3b controlled study in healthy infants'. Together they form a unique fingerprint.
Sort by

Immunology and Microbiology